The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999-2018

被引:1
|
作者
Koohi, Fatemeh [1 ]
Kohansal, Karim [2 ]
Naz, Marzieh Saei Ghare [3 ]
Derakhshan, Somayeh [4 ]
Azizi, Fereidoun [5 ]
Khalili, Davood [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
关键词
Cardiovascular risk score; Risk factors; Diabetes; Trend; Cohort study; DISEASE; POPULATION; EPIDEMIOLOGY; COUNTRY; IRAN;
D O I
10.1186/s12889-022-12981-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Assessing the risk of cardiovascular disease (CVD) is crucial in preventive cardiology. We aimed to determine the trend of CVD risk among individuals with and without diabetes during two decades of follow-up in a Middle Eastern cohort. Methods We studied 8,450 individuals (55.5% women) aged 40-75 years who participated in the Tehran Lipid and Glucose Study (TLGS). Diabetes status and CVD risk factors were evaluated in six examinations from 1999 to 2018. The individual 10-year CVD risk score was calculated using the ACC/AHA recommended risk equation. We used generalized estimating equation models (GEE) to assess the time trends of CVD risk factors and CVD risk scores in diabetic and non-diabetic groups separately. Results The age-adjusted ACC/AHA risk score significantly decreased in non-diabetic women and men (from 3.2% to 1.6% in women and 6.8% to 5.0% in men; p for trend < 0.001). Whereas the risk significantly decreased among diabetics men (from 13.8% to 11.5%), it increased somehow among diabetics women (from 5.3% to 5.5%). Furthermore, in both sexes, diabetic individuals compared to non-diabetic ones had better control on their systolic blood pressure, total cholesterol, and fasting plasma glucose during the last two decades. Conclusions The CVD risk and most CVD risk factors improved in individuals with and without diabetes in the past two decades; however, they have not reached the targets yet. So, more stringent lifestyle modifications and treatment strategies are needed, especially for primary prevention in the general population.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Clinical outcomes of isolated lower extremity or foot burns in diabetic versus non-diabetic patients: A 10-year retrospective analysis
    Kimball, Zachary
    Patil, Sachin
    Mansour, Hani
    Marano, Michael A.
    Petrone, Sylvia J.
    Chamberlain, Ronald S.
    [J]. BURNS, 2013, 39 (02) : 279 - 284
  • [32] Diabetic population mortality and cardiovascular risk attributable to hypertension: A decade follow-up from the Tehran Lipid and Glucose Study
    Bozorgmanesh, Mohammadreza
    Hadaegh, Farzad
    Mohebi, Reza
    Ghanbarian, Arash
    Eskandari, Fatemeh
    Azizi, Fereidoun
    [J]. BLOOD PRESSURE, 2013, 22 (05) : 317 - 324
  • [33] Effect of simvastatin and/or pioglitazone on adiponectin, proinsulin and glucose metabolism in non-diabetic patients at cardiovascular risk -: the PIOSTAT Study
    Wilhelm, B.
    Forst, T.
    Luebben, G.
    Pfuetzner, A.
    Koehler, C.
    Hanefeld, M.
    Karagiannis, E.
    [J]. DIABETOLOGIA, 2006, 49 : 70 - 71
  • [34] Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up†
    Preiss, David
    Welsh, Paul
    Murray, Heather M.
    Shepherd, James
    Packard, Chris
    Macfarlane, Peter
    Cobbe, Stuart
    Ford, Ian
    Sattar, Naveed
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (10) : 1230 - 1236
  • [35] Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes-a 10-year follow-up: Tehran Lipid and Glucose Study
    Afsharian, Sheila
    Akbarpour, Samaneh
    Abdi, Hengameh
    Sheikholeslami, Farhad
    Moeini, Ali Siamak
    Khalili, Davood
    Momenan, Amir Abbas
    Azizi, Fereidoun
    Hadaegh, Farzad
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (06) : 596 - 606
  • [36] Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study
    Amiri, Parisa
    Hosseinpanah, Farhad
    Jalali-Farahani, Sara
    Mehrabi, Yadollah
    Montazeri, Ali
    Azizi, Fereidoun
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (06) : 687 - 693
  • [37] Weight associated cardiovascular risk factors in non-diabetic population - the Sankt Georgen Study
    Jacob, S
    Probst, J
    Keulen, L
    Jacob, F
    Winkler, K
    Balletshofer, B
    Maerz, W
    Lippa, M
    Wahl, HG
    [J]. DIABETES, 2005, 54 : A590 - A590
  • [38] Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
    Quiroga, Borja
    Munoz Ramos, Patricia
    Sanchez Horrillo, Ana
    Ortiz, Alberto
    Manuel Valdivieso, Jose
    Carrero, Juan Jesus
    [J]. CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1705 - 1712
  • [39] The relationship between serum magnesium levels and mortality in non-diabetic hemodialysis patients: A 10-year follow-up study
    Shimohata, Homare
    Yamashita, Marina
    Ohgi, Kentaro
    Tsujimoto, Ryuji
    Maruyama, Hiroshi
    Takayasu, Mamiko
    Hirayama, Kouichi
    Kobayashi, Masaki
    [J]. HEMODIALYSIS INTERNATIONAL, 2019, 23 (03) : 369 - 374
  • [40] Association between weight change and the predicted 10-year risk for atherosclerosis cardiovascular disease among US older adults: data from National Health and Nutrition Examination Survey 1999-2018
    Peng, Yuxuan
    Li, Hongzheng
    Liao, Feifei
    Lu, Jieming
    Yang, Wenwen
    Tan, Ling
    Lu, Aimei
    Wei, Yue
    Long, Linzi
    Qu, Hua
    Fu, Changgeng
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11